- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 14.102 ↓ -0.32%
[as on 6 March, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of Kotak Healthcare Fund - Direct Plan - Growth Option and its peers as on 6 March, 2026
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| Kotak Healthcare Fund - Direct Plan - Growth Option | 2.56% | -0.32% | -1% | 4.48% | 1.06% | 13.54% | - | - | - | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -6.88% | -0.48% | -2.33% | -2.98% | -7.15% | 0.58% | 13.01% | 15.94% | 15.17% | 15.96% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -5.68% | -1.18% | -3.5% | -3.99% | -6.28% | 8.33% | 13.66% | 11.75% | 13.69% | 13.62% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 2.01% | -0.09% | -0.62% | 4.31% | 0.05% | 8.52% | 27.17% | 18.41% | 21.54% | 13.29% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | -4.22% | -0.61% | -3.2% | -3.17% | -3.24% | 8.99% | 20.54% | 19.96% | 19.54% | 17.48% |
| SBI PSU Fund - DIRECT PLAN - GROWTH | 6.09% | -0.46% | -2.93% | 1.91% | 8.44% | 29.55% | 33.66% | 28.09% | 21.61% | 17.17% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | - | - | - | - | - | - | - | - | 42.3% | -5.91% |
Discrete returns (monthly)
| Month | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 |
|---|
| Returns | -0.07% | 3.85% | 3.74% | -1.77% | -1.51% | 2.79% | -0.21% | -2.26% | -4.55% | 7.53% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|
| Returns | -0.16% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 98.71% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
1.29% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | SUNPHARMA (INE044A01036) | Pharmaceuticals and Biotechnology | 13.36% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 7.75% |
| JB Chemicals & Pharmaceuticals Ltd. | JBCHEPHARM (INE572A01036) | Pharmaceuticals and Biotechnology | 5.63% |
| Divis Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals and Biotechnology | 5.60% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals and Biotechnology | 4.68% |
| Fortis Healthcare India Ltd | FORTIS (INE061F01013) | Healthcare Services | 4.25% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 4.23% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals and Biotechnology | 3.88% |
| Ami Organics Ltd | ACUTAAS (INE00FF01025) | Pharmaceuticals and Biotechnology | 3.23% |
| JUBILANT PHARMOVA LIMITED | JUBLPHARMA (INE700A01033) | Pharmaceuticals and Biotechnology | 3.20% |
| ASTER DM HEALTHCARE LTD | ASTERDM (INE914M01019) | Healthcare Services | 3.03% |
| KRISHNA INSTITUTE OF MEDICAL | KIMS (INE967H01025) | Healthcare Services | 3.00% |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals and Biotechnology | 2.81% |
| SAI LIFE SCIENCES LIMITED | SAILIFE (INE570L01029) | Pharmaceuticals and Biotechnology | 2.77% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals and Biotechnology | 2.52% |
| ANTHEM BIOSCIENCES LTD | ANTHEM (INE0CZ201020) | Pharmaceuticals and Biotechnology | 2.51% |
| Dr.Reddy's Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals and Biotechnology | 2.49% |
| MANKIND PHARMA LTD | MANKIND (INE634S01028) | Pharmaceuticals and Biotechnology | 2.48% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals and Biotechnology | 2.39% |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals and Biotechnology | 2.31% |
| Glenmark Pharmaceuticals Ltd | GLENMARK (INE935A01035) | Pharmaceuticals and Biotechnology | 2.24% |
| LAXMI DENTAL LIMITED | LAXMIDENTL (INE0WO601020) | Healthcare Equipment and Supplies | 1.96% |
| Marksans Pharma Ltd | MARKSANS (INE750C01026) | Pharmaceuticals and Biotechnology | 1.89% |
| Zydus Lifesciences Ltd. | ZYDUSLIFE (INE010B01027) | Pharmaceuticals and Biotechnology | 1.62% |
| INNOVA CAPTABS LTD | INNOVACAP (INE0DUT01020) | Pharmaceuticals and Biotechnology | 1.62% |
| Krsnaa Diagnostics Ltd | KRSNAA (INE08LI01020) | Healthcare Services | 1.61% |
| ORCHID PHARMA LIMITED | ORCHPHARMA (INE191A01027) | Pharmaceuticals and Biotechnology | 1.51% |
| YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD | YATHARTH (INE0JO301016) | Healthcare Services | 1.49% |
| RAINBOW CHILDRENS MEDICARE LTD | RAINBOW (INE961O01016) | Healthcare Services | 1.33% |
| RUBICON RESEARCH LIMITED | RUBICON (INE506V01022) | Pharmaceuticals and Biotechnology | 1.32% |
Portfolio data is as on date 31 October, 2025
NAV history
Kotak Healthcare Fund - Direct Plan - Growth Option - 30 days NAV (Net asset value) history
| Date | NAV |
|---|
| 6 March, 2026 | 14.102 |
| 5 March, 2026 | 14.147 |
| 4 March, 2026 | 13.941 |
| 2 March, 2026 | 14.179 |
| 27 February, 2026 | 14.244 |
| 26 February, 2026 | 14.39 |
| 25 February, 2026 | 14.228 |
| 24 February, 2026 | 14.078 |
| 23 February, 2026 | 14.102 |
| 20 February, 2026 | 13.965 |
| 19 February, 2026 | 13.949 |
| 18 February, 2026 | 14.004 |
| 17 February, 2026 | 13.956 |
| 16 February, 2026 | 13.866 |
| 13 February, 2026 | 13.775 |
| 12 February, 2026 | 13.946 |
| 11 February, 2026 | 13.943 |
| 10 February, 2026 | 13.796 |
| 9 February, 2026 | 13.735 |
| 6 February, 2026 | 13.497 |
| 5 February, 2026 | 13.546 |
| 4 February, 2026 | 13.525 |
| 3 February, 2026 | 13.561 |
| 2 February, 2026 | 13.124 |
| 30 January, 2026 | 13.186 |
| 29 January, 2026 | 13.043 |
| 28 January, 2026 | 13.12 |
| 27 January, 2026 | 13.084 |
| 23 January, 2026 | 13.047 |
| 22 January, 2026 | 13.197 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Kotak Healthcare Fund - Direct Plan - Growth Option?
The latest NAV of Kotak Healthcare Fund - Direct Plan - Growth Option is 14.102 as on 6 March, 2026.
What are YTD (year to date) returns of Kotak Healthcare Fund - Direct Plan - Growth Option?
The YTD (year to date) returns of Kotak Healthcare Fund - Direct Plan - Growth Option are 2.56% as on 6 March, 2026.
What are 1 year returns of Kotak Healthcare Fund - Direct Plan - Growth Option?
The 1 year returns of Kotak Healthcare Fund - Direct Plan - Growth Option are 13.54% as on 6 March, 2026.